Knowledge

Guy Henry Faget

Source đź“ť

456: 416:
This is the Modern Age, the Age of Light. Let us have the truth. Leprosy is not a dirt disease. Leprosy is not due to any sin committed by those who contract it. It is not a retaliation of God against its victims. Leprosy is a germ disease just as tuberculosis, typhoid fever and pneumonia are germ
420:
Therefore, let us all cooperate and pull together—the patients and personnel. Together we will succeed; divided we will fail. Yes, the day shall come when the dread of leprosy too will pass away just as it did for yellow fever, cholera and tuberculosis. Let us have courage; We are making strides
164:
This is the paper written immediately before the promin paper. Toxic effects of this drug were considerable, but among 20 cases, it was effective in 6, and another 2 were also effective but on their road to improvement. One case remained unchanged and 10 cases progressed. In its conclusions, they
156:, and read a paper. In this paper he described the present situation of leprosy in the United States, and the National Leprosarium at Carville with photographs. He hinted important progress would be made in the near future. 417:
diseases. It is no more shameful to be infected with the germs of leprosy than with those of tuberculosis, typhoid or pneumonia. So why discriminate against one of these diseases ? Ignorance is the answer.
411:
This is a message of Faget to leprosy patients which was printed in the Christmas number of the 1941 Star, and therefore is considered to directly address patients for participation in the promin trial.
430:
His discovery paved the way to the complete recovery of leprosy, and many effective chemotherapeutic agents followed. He was honored postmortem at the 7th International Congress of Leprology in
136:. He was a member of the International Leprosy Association (ILA) and a consultant to the Advisory Medical Board of LWM. He died in 1947, as a result of a fall and after being affected by 359:
diseases. It is hoped that further synthesis of sulfa compound may produce a substance which will succeed in saving countless lives in this still dark field of medicine.
193:
became negative in 5 cases (23%). In addition, control studies were conducted, which demonstrated significant differences between the promin group and the
483:
Faget GH et al.(1942) Sulfanilamide in the Treatment of Leprosy Public Health Report Dec 11, 1942(Reprinted in ibid. 121, Supple 1:221-223,2006)
96:
compound, synthesized by Feldman and his co-workers in 1940, which is a chemotherapeutic agent that was determined to be effective against
189:
of patients are examined frequently. Among 22 cases, effective in 15 cases (68%), unchanged in 6 cases (27%), worsened in 1 case(5%), and
181:
The side effects of promin were carefully evaluated, and it was concluded that promin could be safely administered, provided that the
492:
Faget GH, et al. (1943) The Promin Treatment of Leprosy, Public Health Report 58:1729-1741, (Reprint Int J Lepr 34(3), 298-310, 1966)
393:
Faget GH, Pogge RC, Johansen FA, Fite GL, Prejean BM, Gemar F: Present status of promin treatment in leprosy. Int J Lepr 14,30,1946.
540: 421:
forward and upward, out of the valley of darkness, over the mountains of difficulties, and into the sunshiny plains of tomorrow.
474:
Symposium on Tropical Medicine, the Story of Leprosy in the United States, Bull Med Libr Assoc, 30: 349-360, 1942
535: 510:
Courage. Faget GH, The Star 42,6,1. July–August, 1983 (originally in the Christmas issue of the Star 1941)
501:
Nihon Hifuka Zensho, 9,1,"Leprosy", Treatment of leprosy, by Tanimura T, Sakurane T, Kinbara Shuppan, 1954
149: 381:
Faget GH, Pogge RC: Pooled blood plasma transfusion in the treatment of leprosy. Int J Lepr 11,32,1943.
125: 387:
Faget GH, Pogge RC, Johansen FA: Promizole in the treatment of leprosy. Pub Health Rep 61,957,1946.
133: 384:
Faget GH, Pogge RC: Penicillin used unsuccessfully in treatment of leprosy. Int J Lepr 12,7,1944.
396:
Faget GH, Erickson PT: Use of streptomycin in the treatment of leprosy. Int J Lepr 15,146,1947.
434:
in 1958 and at the centennial celebration of the Hansen's Disease Center at Carville in 1994.
121: 530: 525: 378:
Faget GH, Johansen, FA: The diphtheria toxoid treatment of leprosy. Int J Lepr 10,68,1942.
8: 129: 101: 105: 390:
Faget GH, Pogge RC, Johansen FA:Present status of Diasone. Pub Health Rep 61,960,1946.
374:
The following papers are based on a Japanese Book Nihon Hifuka Zensho 9,1, "Leprosy"
170: 84:(1891–1947) was an American medical doctor who revolutionalized the treatment of 519: 356: 194: 166: 137: 61: 352: 109: 97: 153: 148:
On May 7 to 9, 1942, he was invited to the 44th Annual Meeting of the
190: 402:
Faget GH, Erickson PT: Chemotherapy of leprosy. JAMA 136,451,1948.
93: 85: 173:
for leprous lesions, either of the macular or lepromatous type.
89: 72: 431: 186: 182: 351:
Promin can be considered to have opened a new avenue in the
159: 92:, as described in a paper published in 1943. Promin is a 399:
Faget GH:Chemotherapy of leprosy. Int J Lepr 15,7,1947.
120:
For 25 years he was a distinguished officer of the US
197:. Impressive photographs were included in the paper. 60:
Physician, Director of a leper hospital at Carville,
126:
United States Marine Hospital (National Leprosarium)
224:Bacteriologic reversion from positive to negative 176: 200:The original paper contains the following table. 517: 143: 443:Betty Martin (1950): Miracle at Carville. 160:Sulfanilamide in the treatment of leprosy 124:. In 1940 he became the director of the 406: 518: 446:Stanley Stein(1963): Alone No Longer. 88:, by demonstrating the efficacy of 75:in the treatment of leprosy in 1943 13: 71:Discovery of the effectiveness of 14: 552: 450: 289:Lepromatous, moderately advanced 369: 177:The promin treatment of leprosy 541:American public health doctors 504: 495: 486: 477: 468: 1: 437: 309:Neural, moderately advanced 144:Leprosy in the United States 7: 249:Mixed, moderately advanced 150:Medical Library Association 10: 557: 269:Lepromatous, far advanced 104:. He was the grandson of 425: 67: 56: 48: 40: 28: 21: 462: 169:cannot be regarded as a 134:United States of America 115: 423: 367: 536:American leprologists 414: 349: 122:Public Health Service 407:A message from Faget 229:Mixed, far advanced 102:experimental animals 457:photograph of Faget 205: 165:clearly wrote that 130:Carville, Louisiana 203: 106:Jean Charles Faget 16:American physician 348: 347: 79: 78: 44:1947 (aged 55–56) 548: 511: 508: 502: 499: 493: 490: 484: 481: 475: 472: 365: 206: 202: 108:, and father of 19: 18: 556: 555: 551: 550: 549: 547: 546: 545: 516: 515: 514: 509: 505: 500: 496: 491: 487: 482: 478: 473: 469: 465: 453: 440: 428: 409: 372: 366: 363: 179: 162: 146: 118: 82:Guy Henry Faget 36: 33: 24: 23:Guy Henry Faget 17: 12: 11: 5: 554: 544: 543: 538: 533: 528: 513: 512: 503: 494: 485: 476: 466: 464: 461: 460: 459: 452: 451:External links 449: 448: 447: 444: 439: 436: 427: 424: 408: 405: 404: 403: 400: 397: 394: 391: 388: 385: 382: 379: 371: 368: 361: 346: 345: 342: 339: 336: 333: 330: 326: 325: 322: 319: 316: 313: 310: 306: 305: 302: 299: 296: 293: 290: 286: 285: 282: 279: 276: 273: 270: 266: 265: 262: 259: 256: 253: 250: 246: 245: 242: 239: 236: 233: 230: 226: 225: 222: 219: 216: 213: 210: 178: 175: 171:curative agent 161: 158: 145: 142: 117: 114: 77: 76: 69: 68:Known for 65: 64: 58: 54: 53: 50: 46: 45: 42: 38: 37: 34: 30: 26: 25: 22: 15: 9: 6: 4: 3: 2: 553: 542: 539: 537: 534: 532: 529: 527: 524: 523: 521: 507: 498: 489: 480: 471: 467: 458: 455: 454: 445: 442: 441: 435: 433: 422: 418: 413: 401: 398: 395: 392: 389: 386: 383: 380: 377: 376: 375: 360: 358: 357:mycobacterial 354: 343: 340: 337: 334: 331: 328: 327: 323: 320: 317: 314: 311: 308: 307: 303: 300: 297: 294: 291: 288: 287: 283: 280: 277: 274: 271: 268: 267: 263: 260: 257: 254: 251: 248: 247: 243: 240: 237: 234: 231: 228: 227: 223: 220: 217: 214: 211: 208: 207: 201: 198: 196: 195:control group 192: 188: 184: 174: 172: 168: 167:sulfanilamide 157: 155: 151: 141: 139: 138:heart disease 135: 131: 127: 123: 113: 111: 107: 103: 99: 95: 91: 87: 83: 74: 70: 66: 63: 59: 57:Occupation(s) 55: 51: 47: 43: 39: 31: 27: 20: 506: 497: 488: 479: 470: 429: 419: 415: 410: 373: 370:Other papers 353:chemotherapy 350: 199: 180: 163: 147: 119: 110:Maxime Faget 98:tuberculosis 81: 80: 531:1947 deaths 526:1891 births 154:New Orleans 49:Nationality 520:Categories 438:References 218:Stationary 364:Faget GH 362:—  215:Improved 204:Table 1 35:American 355:of the 191:bacilli 94:sulfone 86:leprosy 62:America 52:America 426:Honors 329:Total 212:Number 90:promin 73:promin 463:Notes 432:Tokyo 221:Worse 187:urine 183:blood 209:Type 185:and 116:Life 41:Died 32:1891 29:Born 128:at 100:in 522:: 344:5 335:15 332:22 324:0 304:3 284:0 264:1 244:1 152:, 140:. 132:, 112:. 341:1 338:6 321:0 318:0 315:1 312:1 301:0 298:3 295:6 292:9 281:0 278:0 275:1 272:1 261:o 258:1 255:4 252:5 241:1 238:2 235:3 232:6

Index

America
promin
leprosy
promin
sulfone
tuberculosis
experimental animals
Jean Charles Faget
Maxime Faget
Public Health Service
United States Marine Hospital (National Leprosarium)
Carville, Louisiana
United States of America
heart disease
Medical Library Association
New Orleans
sulfanilamide
curative agent
blood
urine
bacilli
control group
chemotherapy
mycobacterial
Tokyo
photograph of Faget
Categories
1891 births
1947 deaths
American leprologists

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑